BioSpace News Archive

Kidney stones can happen in one or both kidneys. It generally affects people between the age bracket of 30 to 60 years as per the National Health Service.

This collaboration aims to develop a disease modifying treatment for synucleinopathies based on network kinetics of α-synuclein misfolding and aggregation

Cholesterol medicines are in humongous demand as several medical research lines point to the relevance and importance of controlling cholesterol levels in the human body.

Oncopeptides AB, a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, announces that the number of shares and votes in Oncopeptides has changed due to the exercise of warrants under the company’s incentive program.

TeraRecon, the leading provider of AI-driven advanced visualization solutions, announced the expansion of their distribution offering to Change Healthcare customers for their AI-powered Intuition Subscription.

Researchers at Massachusetts General Hospital have developed a deep learning model that identifies imaging biomarkers on screening mammograms to predict a patient’s risk for developing breast cancer with greater accuracy than traditional risk assessment tools.

Up to one-third of adult women who sustain a non-displaced fracture to the ulna bone of the forearm may be victims of intimate partner violence, according to a study being presented at the annual meeting of the Radiological Society of North America.

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) disorders, today announced it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will participate in a fireside chat during the 3rd Annual Evercore ISI HealthCONx Conference. The fireside chat is scheduled to take place on Tuesday, December 1, 2020 at 10:05 AM ET. A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of th

Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will host a conference call and webcast featuring two experts in the science and treatment of chronic graft versus host disease (cG